APOE and Alzheimer disease: Similarly, IGFBP3 knockdown significantly reduced the number of Aβ puncta in AD patient iNs harboring PSEN2 mutation and APOE ε3/3 allele sporadic AD patient iNs (Fig. 5f, g, i).